Share this post on:

Product Name :
Cobomarsen

Search keywords :
Cobomarsen

drugId :
null

Target Vo:
microRNA-155

Target Vo Short Name :
miRNA-155

Moa_Name:
microRNA-155 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Miragen Therapeutics

Active Company_Name :
Viridian Therapeutics Inc

Active Indication_Name:
Leukemia-Lymphoma, Adult T-Cell

In Active Indication_Name:
Lymphoma, T-Cell, Cutaneous

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Taldefgrobep alfa supplier
TRAF2 Rabbit mAb Data Sheet
Phospho-mTOR (Ser2448) Antibody (YA691): Phospho-mTOR (Ser2448) Antibody (YA691) is a non-conjugated and Mouse origined monoclonal antibody about 289 kDa, targeting to Phospho-mTOR (S2448). It can be used for WB,IHC assays with tag free, in the background of Human, Mouse.

Share this post on:

Author: Interleukin Related